期刊文献+

国内某人类免疫缺陷病毒I型(HIV-1)核酸检测试剂盒的自动化应用性能评估 被引量:8

Evaluation of the automatic application performance of a quantitative nucleic acid detection kit for HIV-1
原文传递
导出
摘要 目的对国内某人类免疫缺陷病毒Ⅰ型(HIV-1)核酸定量检测试剂盒的自动化应用性能进行评估。方法收集150份血液样品,用待评试剂和参比试剂及自动化设备进行双盲检测。2种试剂定性结果用符合率和卡方检验等统计方法分析;2种试剂的定量结果用相关性分析、回归分析等统计方法分析。结果 2种试剂检测结果的总体符合率为100.00%,Kappa值为1.00。2种试剂盒定量检测结果的相关性分析显示2种试剂检测结果一致,配对t检验显示2种试剂具有等效性。结论待评试剂和参比试剂对同一血液样本检测结果具有较高的定性符合率、较强相关性以及定量一致性。 Objective To evaluate the performance of the automated application of a kind of domestic nucleic acid quantitative detection kit for human immunodeficiency virus type I( HIV - 1 ). Methods 150 blood samples were collected, and the double blind test was carried out with the reagent and reference reagent. The qualitative results of two kinds of reagents were analyzed by statistical methods such as the coincidence rate of the results and the chi square test. The quantitative results of the two kinds of reagents were analyzed by correlation analysis and regression analysis. Results The total coincidence rate of the two reagents was 100.00% and the Kappa value was 1.00. The correlation analysis of the two kinds of reagent kits showed that the results of the two tests were consistent. The paired t test showed that the two reagents have the same equivalence. Conclusion Through testing the same blood sample, the results of the reagent to be evaluated and the reference reagent have higher qualitative coincidence rate, strong correlation and quantitative agreement.
出处 《中国卫生检验杂志》 CAS 2015年第18期3054-3055,3069,共3页 Chinese Journal of Health Laboratory Technology
基金 河南省防治艾滋病规模化现场流行病学和干预研究(2012ZX10004905)
关键词 人类免疫缺陷病毒I型(HIV-1) 自动化 定量检测试剂盒 性能评估 Human immunodeficiency vires type I Automation Quantitative nucleic acid detection kit Performance evaluation
  • 相关文献

参考文献11

二级参考文献43

  • 1肖瑶,冯基刚,蒋岩.用于HIV感染早期监测及发病率调查的实验室检测技术——STARHS检测法[J].中华流行病学杂志,2005,26(7):544-546. 被引量:6
  • 2吕繁,赵金扣,蒋岩,肖瑶,张伟东.BED HIV-1发病监测方法及其应用[J].中国艾滋病性病,2006,12(2):179-181. 被引量:42
  • 3刘康迈.我国艾滋病流行特点及其对社会经济的影响[N].中国医学论坛报,2002—04-11.
  • 4中华人民共和国卫生部,联合国AIDS规划属,世界卫生组织.中国艾滋病防治联合评估报告.2007.
  • 5Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after sereconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retrovirus,2002,18:295-307.
  • 6Febey JL, Taylor JM, Mnna B, et al. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T cell measurements[J]. J AIDS, 1998,12 : 1581 - 1590.
  • 7Antigoni K, Maria P, Vana, Eleni, et al. Evaluation of the clinical sensitivity for the quantification of humanimmunodeficiency vi- rus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays-LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v]. 5 [J]. Journal of Virological.
  • 8Lesley ES, Lara DN, Jackie M,1Linda E, et al. Evaluation of the Abbott m2000 Real Time Human Immunodeficiency Virus Type 1 (HIV 1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV 1 Assays[J]. Journal of Clinical Microbiology, 2009,47(7) :2209-2217.
  • 9Roche LightCycler Procedure.
  • 10Roche Cobas TaqMan HIV 1 Test Procedure.

共引文献62

同被引文献49

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部